About Animalcare Group
Animalcare Group is a specialist veterinary pharmaceutical and animal health company focused on developing, licensing, and distributing products for companion animals and livestock across European markets.
Headquartered in York, United Kingdom, and listed on AIM (the London Stock Exchange's growth market) under the ticker ANCR, the Group operates primarily through its own branded veterinary medicines portfolio alongside a distribution arm that brings third-party products to market. Its commercial reach extends across the United Kingdom, continental Europe, and selected international territories, with a model built on both direct sales forces and distribution partnerships.
The company's product range spans companion animal health and production animal health, covering categories including anaesthesia and analgesia, reproductive management, vaccines, anti-infectives, and nutraceuticals. Within companion animal care, the Group addresses small animal veterinary practice needs across dogs, cats, and equine species. Its production animal portfolio targets cattle and sheep farming sectors, reflecting the mixed-practice realities of its core European markets.
Animalcare Group has grown in part through acquisition, having combined with Ecuphar NV in 2018, a move that significantly expanded its European commercial infrastructure and product portfolio. This transaction established the Group as a mid-scale pan-European veterinary pharmaceuticals business rather than a purely UK-focused distributor, broadening both its regulatory footprint and its direct-to-vet relationships across multiple countries.
The business operates under a veterinary-only sales model, meaning its medicines are prescription or veterinary-directed products supplied through licensed channels rather than consumer retail. This positions the Group squarely within the professional animal health sector alongside larger global competitors.
Further information is available at animalcaregroup.com.
